Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site exfoliation, Vaccination site induration, Vaccination site pruritus
Clinical narrative: injection site was itchy; injection site was hard; injection site was peeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient received bnt162b2 (BNT162B2), on 26Jan2022 as dose 4 (booster), single (Lot number: EL3249) at the age of 52 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "concussions", start date: 2015 (unspecified if ongoing), notes: she was in an ice storm and had concussions and contusions, this occurred in 2015; "contusion", start date: 2015 (unspecified if ongoing), notes: she was in an ice storm and had concussions and contusions, this occurred in 2015; "She had an accident" (unspecified if ongoing), notes: She had an accident and had a torn rotator cuff and she was getting different injections; "torn rotator cuff" (unspecified if ongoing), notes: She had an accident and had a torn rotator cuff and she was getting different injections. There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Lot: EL0149 , Expiration: unknown, NDC: unknown), administration date: 05Jan2021, when the patient was 51-year-old, for COVID-19 Immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; bnt162b2 (DOSE 2, SINGLE, Lot: PAA156051,, Expiration: unknown, NDC: unknown), administration date: 27Jan2021, when the patient was 51-year-old, for COVID-19 Immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling"; bnt162b2 (DOSE 3 (BOOSTER), SINGLE, Lot: EL0140, Expiration: unknown, NDC: unknown), administration date: 06Jun2021, when the patient was 51-year-old, for COVID-19 Immunization, reaction(s): "injection site was itchy", "injection site was hard", "injection site was peeling". The following information was reported: VACCINATION SITE INDURATION (non-serious) with onset 2022, outcome "recovered", described as "injection site was hard"; VACCINATION SITE PRURITUS (non-serious) with onset 2022, outcome "recovered", described as "injection site was itchy"; VACCINATION SITE EXFOLIATION (non-serious) with onset 2022, outcome "recovered", described as "injection site was peeling". Therapeutic measures were taken as a result of vaccination site pruritus, vaccination site induration, vaccination site exfoliation.  Additional information: Patient called about Pfizer Biontech covid 19 vaccine and asked when the new covid 19 vaccine will be available. She also asked about tetanus and flu vaccine and agent referred her to the manufacturer since Pfizer does not have a tetanus or flu vaccine. Reported she took all of the Pfizer covid vaccines including the booster. States that when the injection site was healing it was itchy, hard, and she took a Tylenol. She did not have adverse reactions, only when it was healing. PCP told her to go to the pharmacy and the pharmacy did not have the flu shot. it was after all the covid vaccine doses she was given, where the injection site was itchy, hard, and peeling. it took about 3 or 4 days to recover after each dose of the covid vaccine. She did not pay attention to it. They told her to exercise and move her arm around. She had 7 Pfizer covid vaccines. She was in physical rehabilitative facility when she got this dose. She was hoping that they did not write down the flu shot on this vaccination card. She was given a flu shot and covid booster shot on the same date. Flu shot and covid shot were given in opposite arms. Unknown which dose she was referring to where she was given flu shot on the same date. She had an accident and had a torn rotator cuff and she was getting different injections. states she was in an ice storm and had concussions and contusions, this occurred in 2015. Once get it people have been lying and go back and go in the crowd.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300298937 same patient/AE, different product;US-PFIZER INC-202300299879 same patient/product/AE, different dose number;